does glp-1 cause cancer Increase Risk of Cancer? FDA Data and Safety Evidence Could GLP-1 medications help slow

These medications work by mimicking glucagon-like peptide-1, a hormone naturally produced by the body that plays a key role in appetite regulation, digestion, and metabolic function

For example, the SELECT trial revealed that patients on semaglutide maintained an average weight loss of -10.2% over four years (208 weeks), while the placebo group only saw a modest -1.5% reduction

Clin Epidemiol 11:349358

suctioning and rapid intubation were required

In 2026, Novo Nordisk extended the lineup with Wegovy HD at 7.2 mg, where weight reduction approached 2021%

Tirzepatide (Zepbound, Mounjaro) Tirzepatide is a first-in-class dual agonist